Seeing Is Believing
VOR is currently covered by 8 analysts with an average price target of $10.87. This is a potential upside of $10.7 (6294.12%) from yesterday's end of day stock price of $0.17.
Vor Biopharma's activity chart (see below) currently has 15 price targets and 40 ratings on display. The stock rating distribution of VOR is 100% BUY.
Highest price target for VOR is $3, Lowest price target is $3, average price target is $10.67.
Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 30-Dec-2024. First documented stock forecast 02-Mar-2021.
Currently out of the existing stock ratings of VOR, 25 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4 months 12 days ago
(30-Dec-2024)
0/6 (0%)
$9.12 (316.67%)
Buy
5 months 2 days ago
(10-Dec-2024)
0/5 (0%)
$12.58 (255.69%)
Buy
$22
6 months 4 days ago
(08-Nov-2024)
0/2 (0%)
$16.12 (274.15%)
Buy
$3
$2 (200.00%)
$10
8 months 28 days ago
(14-Aug-2024)
0/4 (0%)
$2.17 (261.45%)
Buy
11 months 29 days ago
(13-May-2024)
0/4 (0%)
$13.58 (307.24%)
What is VOR (Vor Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on VOR (Vor Biopharma) with a proven track record?
Which analyst has the current lower performing score on VOR (Vor Biopharma) with a proven track record?
Which analyst has the most public recommendations on VOR (Vor Biopharma)?
Which analyst is the currently most bullish on VOR (Vor Biopharma)?
Which analyst is the currently most reserved on VOR (Vor Biopharma)?